E. Pittermann

547 citations

34 papers · 398 indexed · h-index 8

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- BRCA gene mutations in cancer
- Chronic Lymphocytic Leukemia Research

Papers in ⓘ

Hematology 15
- Acute Myeloid Leukemia Research 13
Genetics 9
- Chronic Lymphocytic Leukemia Research 5
- Hemoglobinopathies and Related Disorders 2

Co-authors: Michael Pfeilstöcker (16 shared papers)Thomas Nösslinger (7 shared papers)Heinz Tüchler (7 shared papers)Hadwiga Nowotny (3 shared papers)R. Heinz (11 shared papers)Elisabeth Koller (6 shared papers)Ernst Schlögl (2 shared papers)Peter J. Oefner (1 shared paper)
Journals: Annals of Hematology (6 papers)Leukemia Research (5 papers)Journal of Molecular Medicine (2 papers)Blood (2 papers)Stem Cells (1 paper)
Partner nations: Austria Slovakia United States

In The Last Decade

E. Pittermann

31 papers receiving 377 citations

Peers

Countries citing papers authored by E. Pittermann

Since Specialization

Citations

This map shows the geographic impact of E. Pittermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Pittermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Pittermann more than expected).

Fields of papers citing papers by E. Pittermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Pittermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Pittermann. The network helps show where E. Pittermann may publish in the future.

Co-authors

The 25 scholars most cited alongside E. Pittermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Pittermann Line = papers co-authored together E. Pittermann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution Blood ·Thomas Nösslinger, Regina Reisner, Elisabeth Koller, Helga Grüner, Heinz Tüchler, Hadwiga Nowotny, E. Pittermann, Michael Pfeilstöcker	2001	91
2	Cross‐validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics British Journal of Haematology ·Michael Pfeilstöcker, Regina Reisner, Thomas Nösslinger, Helga Grüner, Hadwiga Nowotny, Heinz Tüchler, Ernst Schlögl, E. Pittermann, R. Heinz	1999	67
3	Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations British Journal of Cancer ·Theresa Wagner, Regina Möslinger, (unknown), Regine Ahner, E. Fleischmann, Alexandra Auterith, Alexander Friedmann, Thomas H. Helbich, C C Zielinski, E. Pittermann, Michael Seifert, Peter J. Oefner	2000	67
4	Dysplastic versus proliferative CMML – a retrospective analysis of 91 patients from a single institution Leukemia Research ·Thomas Nösslinger, Regina Reisner, Helga Grüner, Heinz Tüchler, Hadwiga Nowotny, E. Pittermann, Michael Pfeilstöcker	2001	44
5	FACS analysis—a new and accurate tool in the diagnosis of lymphoma in the cerebrospinal fluid Clinica Chimica Acta ·Sabine Urbanits, Andrea Griesmacher, Georg Hopfinger, Günther Stockhammer, Alireza Karimi, Mathias M. Müller, E. Pittermann, Wolfgang Grisold	2002	23
6	Association of GB virus C (GBV-C)/hepatitis G virus (HGV) with haematological diseases of different malignant potential Journal of Medical Virology ·Borislava G. Pavlova, R. Heinz, U Selim, Heinz T�chler, E. Pittermann, Gerald Eder	1999	18
7	Time changes in predictive power of established and recently proposed clinical, cytogenetical and comorbidity scores for Myelodysplastic Syndromes Leukemia Research ·Michael Pfeilstöcker, Heinz Tüchler, Anabel Schönmetzler, Thomas Nösslinger, E. Pittermann	2011	14
8	Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in acute promyelocytic leukemia Annals of Hematology ·Elisabeth Koller, H. Karlic, O. Krieger, Martin Mistrík, G. Michlmayr, Helmut Gadner, D. Lutz, R. Heinz, E. Pittermann	1995	13
9	Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: Open questions Critical Reviews in Oncology/Hematology ·Peter Valent, Günther Gastl, Klaus Geißler, Richard Greil, Oliver Hantschel, Alois Lang, Werner Linkesch, Thomas Lion, Andreas Petzer, E. Pittermann, Lisa Pleyer, Josef Thaler, Dominik Wolf‎	2011	7
10	Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non‐Hodgkin's lymphoma European Journal Of Haematology ·Georg Hopfinger, R. Heinz, Elisabeth Koller, Bryan J. Schneider, E. Pittermann	1995	6
11	Effect of the Hemoregulatory Peptide (pEEDCK)2 (pyroGlu‐Glu‐Asp‐Cys‐Lys)2 and MIP‐1α is Reduced in Bone Marrow Cultures from Patients with Chronic Myeloid Leukemia (CML) Stem Cells ·H. Karlic, Norbert Louda, Michael Pfeilstöcker, Felix Keil, Alfred Lohninger, E. Pittermann, J B Paukovits	2001	6
12	Peptichemio in the therapy of malignancies (phase-I-study). The evaluation committee. PubMed ·N Gingold, E. Pittermann, A Stacher	1974	6
13	Monitoring of hematopoietic recovery after autologous stem cell transplantation by analysis of G alpha 16 mRNA and CD34 surface glycoprotein Annals of Hematology ·Michael Pfeilstöcker, H. Karlic, J Salamon, H. Mühlberger, Borislava G. Pavlova, U Selim, Herbert Strobl, E. Pittermann, R. Heinz	1998	5
14	Therapeutische, funktionelle und kinetische Aspekte der Leukopheresetherapie chronischer lymphatischer Leukämien Annals of Hematology ·P Höcker, E. Pittermann, Marianne Gobets, Brigitte Haist, Marguerite Gazda, A Stacher	1974	3
15	In vivo and in vitro effects of cytokines and the hemoregulatory peptide dimer (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 on Gα16-positive hematopoiesis Leukemia ·Michael Pfeilstöcker, H. Karlic, J B Paukovits, G Anzenberger, Norbert Louda, J Salamon, H. Mühlberger, Herbert Strobl, E. Pittermann, R. Heinz	1999	3
16	Hematopoietic recovery after IEV chemotherapy for malignant lymphoma followed by different cytokines can be monitored by analysis of Gα 16 and CD34 American Journal of Hematology ·Michael Pfeilstöcker, H. Karlic, J Salamon, H. Mühlberger, Borislava G. Pavlova, Herbert Strobl, E. Pittermann, R. Heinz	2000	3
17	Assessment of growth and differentiation processes in myelodysplastic syndromes by PCR analysis of Gα16 and 5′-lipoxygenase Annals of Hematology ·Michael Pfeilstöcker, Heidrun Karlic, Thomas Nösslinger, Heinz Tüchler, Alfred Lohninger, E. Pittermann	2002	2
18	[Plasma exchange therapy in hematology]. PubMed ·P Höcker, E. Pittermann	1985	2
19	Tumor-Stammzellforschung – Basis und Herausforderung für Diagnostik und Therapie Wiener klinische Wochenschrift ·Heidrun Karlic, Harald Herrmann, Axel Schulenburg, Thomas W. Grunt, Sylvia Laffer, Irina Mirkina, Rainer Hubmann, Medhat Shehata, Brigitte Marian, Edgar Selzer, Michael Pfeilstöcker, E. Pittermann, Ulrich Jäger, Hubert Pehamberger, Christoph Zielinski, Peter Valent	2010	2
20	[An unusual case of repeated self mutilation (author's transl)]. PubMed ·Fritz Gschnait, William E. Brenner, Eva Berger, Mikołaj Eibl, F Horn, P Höcker, E. Pittermann	1981	2

About E. Pittermann

E. Pittermann is a scholar working on Hematology, Genetics, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 398 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Retinoids in leukemia and cellular processes (4 papers), Metabolism and Genetic Disorders (3 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Hemoglobinopathies and Related Disorders (2 papers). The work is most often cited by research in Hematology (253 citations), Genetics (127 citations), Emergency Medicine (45 citations), Pathology and Forensic Medicine (72 citations) and Genetics (81 citations). E. Pittermann has collaborated with scholars based in Austria, Slovakia and United States. Frequent co-authors include Michael Pfeilstöcker, Thomas Nösslinger, Heinz Tüchler, Hadwiga Nowotny, R. Heinz, Elisabeth Koller, Ernst Schlögl, Peter J. Oefner, Alexander Friedmann and Alexandra Auterith. Their work appears in journals such as Annals of Hematology, Leukemia Research, Journal of Molecular Medicine, Blood and Stem Cells.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact